Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 9 | 2023 | 688 | 1.200 |
Why?
|
| Cartilage, Articular | 7 | 2019 | 550 | 0.950 |
Why?
|
| Tendon Injuries | 5 | 2014 | 205 | 0.940 |
Why?
|
| Rotator Cuff | 4 | 2014 | 283 | 0.850 |
Why?
|
| Knee Injuries | 5 | 2014 | 238 | 0.830 |
Why?
|
| Tissue Engineering | 2 | 2012 | 39 | 0.790 |
Why?
|
| Arthroplasty, Replacement, Hip | 7 | 2023 | 860 | 0.750 |
Why?
|
| Platelet-Rich Plasma | 6 | 2017 | 86 | 0.660 |
Why?
|
| Arthroscopy | 8 | 2019 | 892 | 0.640 |
Why?
|
| Osteoarthritis, Knee | 5 | 2021 | 400 | 0.610 |
Why?
|
| Transplantation, Homologous | 4 | 2014 | 295 | 0.560 |
Why?
|
| Rotator Cuff Injuries | 5 | 2014 | 298 | 0.560 |
Why?
|
| Knee Joint | 6 | 2023 | 826 | 0.550 |
Why?
|
| Knee Prosthesis | 1 | 2019 | 240 | 0.530 |
Why?
|
| Biomechanical Phenomena | 2 | 2011 | 698 | 0.410 |
Why?
|
| Orthopedic Procedures | 3 | 2012 | 329 | 0.410 |
Why?
|
| Arthralgia | 1 | 2013 | 133 | 0.400 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 46 | 0.390 |
Why?
|
| Arthritis, Infectious | 2 | 2023 | 63 | 0.390 |
Why?
|
| Retrospective Studies | 10 | 2023 | 3658 | 0.360 |
Why?
|
| Humans | 28 | 2023 | 30959 | 0.340 |
Why?
|
| Prosthesis-Related Infections | 2 | 2023 | 222 | 0.340 |
Why?
|
| Quality of Life | 1 | 2013 | 697 | 0.310 |
Why?
|
| Reoperation | 4 | 2022 | 950 | 0.290 |
Why?
|
| Hyaluronic Acid | 3 | 2017 | 102 | 0.290 |
Why?
|
| Shoulder | 3 | 2015 | 167 | 0.290 |
Why?
|
| Middle Aged | 12 | 2019 | 10192 | 0.260 |
Why?
|
| Male | 14 | 2022 | 16425 | 0.250 |
Why?
|
| Female | 14 | 2022 | 16965 | 0.240 |
Why?
|
| Young Adult | 7 | 2019 | 2060 | 0.240 |
Why?
|
| Adult | 9 | 2019 | 8924 | 0.230 |
Why?
|
| Urinary Retention | 1 | 2022 | 12 | 0.210 |
Why?
|
| Risk | 2 | 2023 | 220 | 0.210 |
Why?
|
| Cholecalciferol | 1 | 2022 | 7 | 0.210 |
Why?
|
| Wound Healing | 2 | 2015 | 174 | 0.210 |
Why?
|
| Tibial Meniscus Injuries | 2 | 2014 | 98 | 0.210 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 34 | 0.210 |
Why?
|
| Anesthesia, Conduction | 1 | 2022 | 30 | 0.200 |
Why?
|
| Venous Thrombosis | 1 | 2023 | 45 | 0.200 |
Why?
|
| Orthopedic Surgeons | 1 | 2022 | 29 | 0.200 |
Why?
|
| Injections, Intra-Articular | 5 | 2022 | 97 | 0.200 |
Why?
|
| Menisci, Tibial | 2 | 2014 | 187 | 0.200 |
Why?
|
| Shoulder Impingement Syndrome | 2 | 2011 | 13 | 0.200 |
Why?
|
| Anesthetics, Local | 1 | 2022 | 97 | 0.190 |
Why?
|
| Polyethylene | 2 | 2019 | 121 | 0.190 |
Why?
|
| Surgeons | 2 | 2019 | 87 | 0.190 |
Why?
|
| Absorbable Implants | 2 | 2011 | 26 | 0.190 |
Why?
|
| Prosthesis Design | 2 | 2019 | 507 | 0.170 |
Why?
|
| Joint Diseases | 1 | 2021 | 114 | 0.170 |
Why?
|
| Pain Measurement | 3 | 2022 | 489 | 0.170 |
Why?
|
| Fractures, Stress | 1 | 2019 | 24 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 190 | 0.160 |
Why?
|
| Perioperative Care | 1 | 2019 | 56 | 0.160 |
Why?
|
| Prosthesis Failure | 2 | 2019 | 539 | 0.160 |
Why?
|
| Odds Ratio | 1 | 2019 | 291 | 0.150 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2019 | 77 | 0.150 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 817 | 0.150 |
Why?
|
| Postoperative Period | 1 | 2019 | 302 | 0.150 |
Why?
|
| Patient Discharge | 1 | 2019 | 164 | 0.150 |
Why?
|
| Joint Instability | 2 | 2011 | 405 | 0.140 |
Why?
|
| Adolescent | 5 | 2014 | 2399 | 0.140 |
Why?
|
| Rupture | 2 | 2014 | 121 | 0.140 |
Why?
|
| Tibia | 1 | 2019 | 274 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 1311 | 0.140 |
Why?
|
| Aged | 6 | 2019 | 10047 | 0.140 |
Why?
|
| Synovial Fluid | 1 | 2016 | 127 | 0.130 |
Why?
|
| Chondrogenesis | 1 | 2015 | 31 | 0.130 |
Why?
|
| Arthroplasty, Subchondral | 1 | 2015 | 28 | 0.120 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 434 | 0.120 |
Why?
|
| Cartilage | 2 | 2014 | 159 | 0.120 |
Why?
|
| Achilles Tendon | 1 | 2014 | 19 | 0.120 |
Why?
|
| Acromion | 1 | 2014 | 27 | 0.110 |
Why?
|
| Quadriceps Muscle | 1 | 2014 | 32 | 0.110 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2013 | 18 | 0.110 |
Why?
|
| Bone-Patellar Tendon-Bone Grafting | 1 | 2014 | 46 | 0.110 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 44 | 0.110 |
Why?
|
| Patellar Ligament | 1 | 2014 | 56 | 0.110 |
Why?
|
| Synovial Membrane | 1 | 2013 | 84 | 0.110 |
Why?
|
| Hip Prosthesis | 1 | 2019 | 578 | 0.110 |
Why?
|
| Range of Motion, Articular | 2 | 2014 | 736 | 0.110 |
Why?
|
| Muscle Strength | 1 | 2013 | 136 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2013 | 135 | 0.100 |
Why?
|
| Artificial Cells | 1 | 2012 | 2 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2013 | 298 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2012 | 47 | 0.100 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2011 | 17 | 0.100 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 198 | 0.100 |
Why?
|
| Athletic Injuries | 1 | 2013 | 180 | 0.090 |
Why?
|
| Suture Anchors | 1 | 2011 | 75 | 0.090 |
Why?
|
| Treatment Outcome | 3 | 2016 | 3806 | 0.090 |
Why?
|
| Sutures | 1 | 2010 | 46 | 0.090 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2012 | 274 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 1922 | 0.080 |
Why?
|
| Tendons | 1 | 2011 | 229 | 0.080 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 1 | 2012 | 245 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2010 | 144 | 0.080 |
Why?
|
| Osteoarthritis | 1 | 2013 | 384 | 0.080 |
Why?
|
| Shoulder Injuries | 1 | 2010 | 143 | 0.080 |
Why?
|
| Pain, Postoperative | 2 | 2022 | 334 | 0.080 |
Why?
|
| Shoulder Joint | 2 | 2011 | 605 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2022 | 499 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2016 | 1897 | 0.080 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 551 | 0.070 |
Why?
|
| Postoperative Complications | 2 | 2023 | 991 | 0.070 |
Why?
|
| Iatrogenic Disease | 1 | 2023 | 28 | 0.050 |
Why?
|
| Urinary Catheterization | 1 | 2022 | 7 | 0.050 |
Why?
|
| Urinary Catheters | 1 | 2022 | 5 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 17 | 0.050 |
Why?
|
| Clonidine | 1 | 2022 | 28 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2022 | 18 | 0.050 |
Why?
|
| Ketorolac | 1 | 2022 | 18 | 0.050 |
Why?
|
| Epinephrine | 1 | 2022 | 37 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2022 | 63 | 0.050 |
Why?
|
| Bupivacaine | 1 | 2022 | 57 | 0.050 |
Why?
|
| Vitamin D | 1 | 2022 | 42 | 0.050 |
Why?
|
| United States | 2 | 2022 | 2373 | 0.050 |
Why?
|
| Morphine | 1 | 2022 | 85 | 0.050 |
Why?
|
| Anesthesia, General | 1 | 2022 | 30 | 0.050 |
Why?
|
| Risk Factors | 2 | 2023 | 2586 | 0.050 |
Why?
|
| Arthroplasty | 1 | 2022 | 141 | 0.050 |
Why?
|
| Postural Balance | 1 | 2022 | 124 | 0.050 |
Why?
|
| Pain Management | 1 | 2022 | 144 | 0.050 |
Why?
|
| Radiography | 2 | 2014 | 695 | 0.050 |
Why?
|
| Social Class | 1 | 2021 | 70 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 226 | 0.040 |
Why?
|
| Office Visits | 1 | 2019 | 13 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 426 | 0.040 |
Why?
|
| Outpatients | 1 | 2019 | 57 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2019 | 132 | 0.040 |
Why?
|
| Time Factors | 2 | 2014 | 1672 | 0.040 |
Why?
|
| Hospitals | 1 | 2019 | 165 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 150 | 0.040 |
Why?
|
| Lysholm Knee Score | 1 | 2016 | 8 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2015 | 14 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 22 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 24 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 130 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 81 | 0.030 |
Why?
|
| Rabbits | 1 | 2015 | 286 | 0.030 |
Why?
|
| Acupuncture | 1 | 2013 | 3 | 0.030 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2013 | 7 | 0.030 |
Why?
|
| Viscosupplementation | 1 | 2013 | 8 | 0.030 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2013 | 32 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2013 | 37 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 230 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 2013 | 71 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 61 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 135 | 0.030 |
Why?
|
| Collagen | 1 | 2013 | 103 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 158 | 0.030 |
Why?
|
| Debridement | 1 | 2013 | 104 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2013 | 112 | 0.030 |
Why?
|
| Aggrecans | 1 | 2013 | 157 | 0.030 |
Why?
|
| Allografts | 1 | 2014 | 202 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 103 | 0.030 |
Why?
|
| Gene Expression | 1 | 2013 | 238 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 234 | 0.030 |
Why?
|
| Time-to-Treatment | 1 | 2012 | 37 | 0.030 |
Why?
|
| Observer Variation | 1 | 2012 | 118 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2012 | 21 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2012 | 51 | 0.020 |
Why?
|
| Leukocytes | 1 | 2012 | 46 | 0.020 |
Why?
|
| Benzophenones | 1 | 2011 | 27 | 0.020 |
Why?
|
| Ceramics | 1 | 2011 | 25 | 0.020 |
Why?
|
| Ketones | 1 | 2011 | 22 | 0.020 |
Why?
|
| Synovitis | 1 | 2011 | 23 | 0.020 |
Why?
|
| Polymers | 1 | 2011 | 42 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 59 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2011 | 104 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2012 | 353 | 0.020 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2012 | 281 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2012 | 532 | 0.020 |
Why?
|
| Osteolysis | 1 | 2011 | 147 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 872 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5189 | 0.020 |
Why?
|
| Child | 1 | 2012 | 1428 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 2042 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 4722 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 1210 | 0.020 |
Why?
|